课题基金 / 基金详情

Pilot Clinical Study: Psilocybin Assisted Psychotherapy as a Novel Treatment for Comorbid Major Depressive Disorder (MDD) and Alcohol Use Disorder (AUD).

Pilot Clinical Study: Psilocybin Assisted Psychotherapy as a Novel Treatment for Comorbid Major Depressive Disorder (MDD) and Alcohol Use Disorder (AUD).
试点临床研究：裸盖菇素辅助心理治疗作为共病重度抑郁症 (MDD) 和酒精使用障碍 (AUD) 的新型治疗方法。
批准号：
469836
负责人：
Le Foll Bernard
金额：
$25.08万
依托单位：
Centre for Addiction and Mental Health (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-09-01 至 2025-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=469836&lang=en
关键词：
Alcohol Use Disorder Clinical Trial Major Depressive Disorder Mental Health Neuroscience Pharmacology Psychedelics Psychiatry Therapy Treatment

项目摘要

项目成果

Le Foll Bernard的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Alcohol use disorder (AUD) is one of the most common substance use disorders in Canada and the sixth leading cause for death and disability nationally. Major depressive disorder (MDD) is a severe burden to global public health. It is estimated to affect m
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The collateral effects of COVID-19 public health policies: Perspectives of people who use opioids and those closest to them using a patient-oriented research approach
Cytisine: testing its potential as a therapeutic strategy for smoking cessation in subjects with concurrent alcohol use disorder
Using ECHO to Address the Needs of Francophone Addiction Service Providers in Ontario
Understanding Cannabis Use and Perceptions in Patients with Substance Use Disorders and Concurrent Disorders
海外基金